Replies to post #91186 on Biotech Values

[DewDiligence]

Amusing that Regulus is entering the HCV arena. You probably know that Kleanthis Xanthopoulos was the CEO of ANDS who departed under a cloud only two weeks before ANDS disclosed that its lead drug had bombed (#msg-11589918).